CD4 and cervical carcinoma: For example, the long peptide containing E6 and E7 proteins of Human Papilloma virus can be presented by both HLA Class I and II pathways, and showed efficacy in eliciting both CD4 and CD8 T cell responses which reduced tumor burden in cervical cancer patients [37, 38].